Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 25. August 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16706  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 334103  
   
Medicaid Expansion and Overall Mortality in Lung, Breast, and Colorectal Cancer: A Difference-in-Differences Study.
Am Surg
Akinyemi O, Heath JB, Oyebanji O, Fasokun M, Akinwumi B, Nnorom S, Ogunyankin F, Hughes K, Cornwell E 3rd, Levy G.
PMID: 42640027 [PubMed - as supplied by publisher]


Breast Cancer Knowledge, Awareness and Screening Practices Among Female Healthcare Workers in Al-Mukalla, Yemen.
Sultan Qaboos Univ Med J
Al Shoaeeb W, Badheeb AM, Ahmed F, Bawazir A, Nabhan AB, Badheeb M, Bayazid A.
PMID: 42639501 [PubMed - indexed for MEDLINE]


Skeletal Muscle Mass in Women With Breast Cancer: Evaluation of Agreement Between Different Methods.
J Nutr Metab
Souza JAN, Dos Santos DM, da Silva LBL, Garcia MRPDS, Rechinelli AB, Machado JM, Albergaria BH, Bernabé RAM, Marques-Rocha JL, Guandalini VR.
PMID: 42639370 [PubMed]


Physical activity, sedentary behavior, and metabolic-reproductive health in women with PMOS (PCOS): a narrative review of mechanisms, clinical evidence, and individualized intervention strategies.
Front Endocrinol (Lausanne)
Huang X, Chen Z, Zhang L, Li J.
PMID: 42638986 [PubMed - indexed for MEDLINE]


Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1.
Front Immunol
Zhang Z, Zhao R, Hu Y, Xie Q, Yu Y, Li K, Ding Z, Wang M.
PMID: 42638924 [PubMed - indexed for MEDLINE]


Epigenetic mechanisms and clinical translation in ovarian cancer: from molecular pathways to precision therapy.
Biosci Rep
Alsamman K.
PMID: 42638590 [PubMed - indexed for MEDLINE]


Second Breast-Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes.
Int J Cancer
Cheptea C, Kirova Y, Mitrica RI, Badea M, Loap P.
PMID: 42638516 [PubMed - as supplied by publisher]


Immuno-PET imaging of mesothelin in ovarian cancer with (68)Ga-XH04: a first-in-human study.
Biomark Res
Deng Y, Zhang X, Pan Z, Lv X, Lin Z, Feng Y, Wu Z, Song X, Gai Y, Yin H, Zhu J, Jiang D, Lan X.
PMID: 42638115 [PubMed]


AI-based multimodal fusion for preoperative prediction of breast microcalcifications: combining mammography and tomosynthesis.
BMC Med Imaging
Wei J, Li J, Pan R, Cao M, Ma C, Xie Z, Ma Y, Gao Z.
PMID: 42638095 [PubMed - indexed for MEDLINE]


Interventional Radiology in the Management of Breast Cancer: Current Role and Future Directions.
Cardiovasc Intervent Radiol
Plastira C, Panourgias E, Chatziioannou A, Krokidis M.
PMID: 42637827 [PubMed - as supplied by publisher]


Metaplastic breast cancer: A single-centre retrospective experience.
Surgeon
Siddiky S, Nayeem SR, McLean NR, Youssef M, Humphreys A.
PMID: 42637650 [PubMed - as supplied by publisher]


Variation in chemotherapy delivery among patients with advanced epithelial ovarian cancer in the Netherlands and its association with survival: a nationwide cohort study.
Int J Gynecol Cancer
Said SA, Wenzel HHB, van Altena AM, Walraven JEW, IntHout J, de Hullu JA, van der Aa MA.
PMID: 42637596 [PubMed - as supplied by publisher]


Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Ann Oncol
Garber JE, Cameron D, Campbell C, Yothers G, Taboada M, El-Abed S, Rastogi P, McConnell R, Correa A, Delaloge S, Liu WT, Sharma P, Bergh J, Janni W, Balmaña J, Loman N, , Friedman S, Freeman T, Armstrong A, Korde L, Im S, Sagara Y, Viale G, Bliss J, Gianni L, Jóhannsson Ó, Zoppoli G, De Dueñas EM, Marmé F, Fein L, Arnedos M, Ford J, Schmutzler R, Loibl S, Linderholm B, Lakhani SR, Gnant M, Gelmon K, Domchek SM, Senkus E, Eisen A, Jager A, Piccart M, Phillips KA, Traina T, Stickeler E, Singer CF, Shao Z, Liu X, Tipping H, Aktan G, Martinez M, Canon JL, Takahashi M, Yasojima H, Middleton K, Pristauz-Telsnigg G, Pfeiler G, Virani S, Valdes-Albini F, Wolmark N, Mesa ID, Paterson V, Gelber RD, Geyer CE Jr, Tutt ANJ.
PMID: 42636977 [PubMed - as supplied by publisher]


Triangulating evidence to evaluate selection bias in lifecourse Mendelian randomization studies: a practical framework illustrated by early-life adiposity and breast cancer.
J Clin Epidemiol
Power GM, Sanderson E, Gkatzionis A, Richardson TG, Tilling K, Smith GD, Hemani G.
PMID: 42636914 [PubMed - as supplied by publisher]


Efficacy of immediate lymphatic reconstruction after breast cancer surgery: A systematic review and time-course dynamics meta-analysis.
J Reconstr Microsurg
Chang HJ, Chen KY, Chiu WK, Hoang KD, Pai TW, Sun CY, Chen C.
PMID: 42636877 [PubMed - as supplied by publisher]


Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.
Lancet Oncol
Macchia G, Morganti AG, Taylor A, Concin N, Oaknin A, Lorusso D, Vizzielli G, Nout R, González-Martín A, Pezzulla D, Deodato F, Herrera FG, Jereczek-Fossa BA, Guckenberger M.
PMID: 42636843 [PubMed - indexed for MEDLINE]


Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.
Lancet Oncol
Gunster JLB, Tramm T, Machiels M, Demaria S, Formenti SC, de Caluwe A, Duane F, Klein J, Sur D, Somaiah N, Rakovitch E, Jerzak KJ, Lu FI, Hiley CT, Brackstone M, Ehinger A, Maley SK, Acs B, Zerdes I, Ozcan D, Khramtsov A, Salido E, Papathomas TG, Sharma P, Stecklein S, Khramtsova G, Horvath Z, Markov D, Hardas A, do Prado Moura JF, Ramirez A, Woodward WA, Sivapiragasam A, Denkert C, Michiels S, Loi S, Poortmans P, Mutter RW, Salgado R, Tran WT, International Immuno-Oncology Biomarker Working Group.
PMID: 42636842 [PubMed - indexed for MEDLINE]


Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
Lancet Oncol
Dixon-Douglas JR, Drubay D, Salgado R, Acs B, van der Laak J, Yuan Y, Amgad M, Cooper L, Hagos Y, AbdulJabbar K, Meakin J, van Ginneken B, Yan H, Lemonnier J, Penault-Llorca F, Lacroix-Triki M, Joensuu H, Kellokumpu-Lehtinen PL, Loibl S, Denkert C, Viale G, Colleoni MA, Sotiriou C, Piccart M, Dieci MV, Demaria S, Kammler R, Wolff AC, Sparano JA, Adams S, Badve S, Gray RJ, Curigliano G, Salomon AV, Nielsen TO, Pusztai L, Ciompi F, Michiels S, Loi S, International Immuno-Oncology Biomarker Working Group.
PMID: 42636839 [PubMed - indexed for MEDLINE]


Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.
Lancet Oncol
Lara González LE, Giudici F, Salgado R, Yan H, Rojo F, Comerma L, Wienert S, Palacios J, Kos Z, de Haas SL, Rodriguez-Lescure A, Viale G, Zheng Y, Gao D, Kiermaier A, Andre F, Loibl S, Piccart MJ, Gelber R, Cameron D, Krop IE, Savas P, Nielsen TO, Denkert C, Michiels S, Loi S, APHINITY Steering Committee and Investigators and The International Immuno-Oncology Biomarker Working Group.
PMID: 42636838 [PubMed - indexed for MEDLINE]


Solid papillary carcinoma of the breast: A clinicopathological study with emphasis on unusual immunohistochemical and genetic features.
Pathol Res Pract
Hu B, Wang T, Yu J, Yan W.
PMID: 42636673 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 334103    Seite 1 von 16706  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1